Vincristine and Peripheral Neuropathy in Acute Lymphoblastic Leukemia Children
DOI:
https://doi.org/10.31584/jhsmr.2023989Keywords:
acute lymphoblastic leukemia, peripheral neuropathy, vincristineAbstract
Objective: Peripheral neuropathy is a common neurological side effect in acute lymphoblastic leukemia (ALL) pediatric patients, receiving vincristine treatment. This study aims to explore the frequency, clinical, and electrodiagnosis of peripheral neuropathy of ALL patients.
Material and Methods: This study was a retrospective cohort study, using medical record reviews of children who, diagnosed and undergoing treatment for acute lymphoblastic leukemia, from 1st January 2018 till 31st December 2022.
Results: One hundred and ninety-seven patients were diagnosed with ALL and received chemotherapy. Ten patients had clinical and electrodiagnostic studies of peripheral neuropathy. B-cell type and high- risk classification were the most common in these patients. The most common symptom was bilateral foot drop and all patients had hyporeflexia. The mean cumulative dose of vincristine was 13.35±2.12 mg/m2. The axonal neuropathy, with motor dominantly and the peroneal nerves, were the highest abnormal finding in electrodiagnosis testing.
Conclusion: This report addresses the frequent and clinical of patients with peripheral neuropathy. Foot drop and hyporeflexia might be helpful in early detection of peripheral neuropathy in ALL patients.
References
England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the american academy of neurology, the american association of electrodiagnostic medicine, and the american academy of physical medicine and rehabilitation. Neurology 2005;64:199–207.
Peterson CC, Demanelis K, Rentschler K, Meza R, Sriplung H, Wiangnon S, et al. Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011. Pediatr Blood Cancer 2019;66:e27428. doi: 10.1002/ pbc.27428
Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 2012;82:51-77.
Kava M, Walsh P, Srinivas Jois R, Cole C, Lewis B, Nagarajan L. Clinical and electrophysiological characteristics of vincristine induced peripheral neuropathy in children during cancer chemotherapy: does vitamin e have a role. JICNA 2017;17;75. doi: 10.17724/jicna.2017.75
Beijers AJ, Jongen JL, Vreugdenhil G. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med 2012;70:18-25.
Custodio C. Electrodiagnosis in cancer rehabilitation. Phys Med Rehabil Clin N Am 2017;28:193-203.
Jeong JG, Ahn CH, Min YS, Kim SE, Kim JY, Jung TD. Electrophysiologic pattern s of symptomatic vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J Clin Med 2023;12:686. doi: 10.3390/jcm12020686
Tay C, Lee V, Ong L, Goh K, Ariffin H, Fong C. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2017;64:10.1002/ pbc.26471. doi: 10.1002/pbc.26471
Gilchrist L. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients. Semin Pediatr Neurol 2012;19:9-17.
Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33:15-49.
van de Velde ME, van den Berg MH, Kaspers GJL, Abbink FCH, Twisk JWR, van der Sluis IM, et al. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer. Cancer Med 2021;10:8172-81.
Özdemir B, Gerçeker GO, Özdemir EZ, Yıldırım BG, Ören H, Yiş U et al. Examination of the psychometric properties of pediatric-modified total neuropathy score in turkish children with cancer. J Pediatr Nurs 2023;69:31-7.
Jain P, Gulati S, Seth R, Bakhshi S, Toteja G, Pandey R. Vincristine-induce neuropathy in childhood all (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics. J Child Neurol 2014;29:932-7.
Vivas-Rosales IJ, Garcia-Saaverdra L, Martin-Trejo JA, Mejia-Arangure JM, Victorio-Garcia NP, Herrera-Landero A, et.al. Chemotherapy-induced peripheral neuropathy is a subpopulation mexican pediatric patients with acute lymphoblastic leukemia. Iran J Pediatr 2017;27:e11844. doi: 10.5812/ijp.11844.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
